|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net increase (decrease) in net assets resulting from operations | |||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
| Amortization of deferred financing costs | |||
| Net accretion of discount on investments | |||
| Paid-in-kind interest | |||
| Net realized (gain) loss on investments | |||
| Net realized currency (gain) loss on non-investment assets and liabilities | |||
| Net change in unrealized (appreciation) depreciation on investments | |||
| Net change in unrealized currency (gain) loss on non-investment assets and liabilities | |||
| Net change in unrealized (gain) loss on forward currency contracts | |||
| Cost of investments purchased and change in payable for investments purchased | |||
| Proceeds from sales and repayments of investments and change in receivable for investments sold | |||
| Changes in operating assets: | |||
| Interest receivable | |||
| Prepaid expenses and other assets | |||
| Changes in operating liabilities: | |||
| Due to Investment Adviser | |||
| Interest and credit facility fees payable | |||
| Management and incentive fees payable | |||
| Administrative service fees payable | |||
| Other accrued expenses and liabilities | |||
| Net cash provided by (used in) operating activities | |||
| Cash flows from financing activities: | |||
| Proceeds from issuance of common stock, inclusive of common stock proceeds received in advance | |||
| Repurchase of common stock | |||
| Borrowings on Credit Facilities | |||
| Repayments of Credit Facilities | |||
| Proceeds from issuance of 2024-1 Debt | |||
| Dividends paid in cash | |||
| Debt issuance costs paid | |||
| Net cash provided by (used in) financing activities | |||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||
| Cash, cash equivalents and restricted cash, beginning of year | |||
| Cash, cash equivalents and restricted cash, end of year | |||
| Supplemental disclosures: | |||
| Interest and credit facility fees paid during the year | |||
| Taxes, including excise tax, paid during the year | |||
| Dividends declared during the year | |||
| Dividends reinvested during the year |
Loading...